全文获取类型
收费全文 | 3295篇 |
免费 | 202篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 185篇 |
妇产科学 | 49篇 |
基础医学 | 421篇 |
口腔科学 | 83篇 |
临床医学 | 279篇 |
内科学 | 747篇 |
皮肤病学 | 61篇 |
神经病学 | 161篇 |
特种医学 | 536篇 |
外科学 | 330篇 |
综合类 | 66篇 |
一般理论 | 2篇 |
预防医学 | 167篇 |
眼科学 | 19篇 |
药学 | 183篇 |
中国医学 | 28篇 |
肿瘤学 | 194篇 |
出版年
2023年 | 10篇 |
2022年 | 29篇 |
2021年 | 66篇 |
2020年 | 39篇 |
2019年 | 68篇 |
2018年 | 63篇 |
2017年 | 45篇 |
2016年 | 64篇 |
2015年 | 81篇 |
2014年 | 84篇 |
2013年 | 127篇 |
2012年 | 143篇 |
2011年 | 131篇 |
2010年 | 120篇 |
2009年 | 106篇 |
2008年 | 100篇 |
2007年 | 93篇 |
2006年 | 91篇 |
2005年 | 75篇 |
2004年 | 86篇 |
2003年 | 96篇 |
2002年 | 86篇 |
2001年 | 75篇 |
2000年 | 69篇 |
1999年 | 69篇 |
1998年 | 153篇 |
1997年 | 141篇 |
1996年 | 139篇 |
1995年 | 111篇 |
1994年 | 91篇 |
1993年 | 92篇 |
1992年 | 57篇 |
1991年 | 41篇 |
1990年 | 37篇 |
1989年 | 73篇 |
1988年 | 65篇 |
1987年 | 73篇 |
1986年 | 62篇 |
1985年 | 62篇 |
1984年 | 34篇 |
1983年 | 37篇 |
1982年 | 34篇 |
1981年 | 23篇 |
1980年 | 41篇 |
1979年 | 16篇 |
1978年 | 21篇 |
1977年 | 20篇 |
1976年 | 26篇 |
1975年 | 26篇 |
1973年 | 6篇 |
排序方式: 共有3528条查询结果,搜索用时 15 毫秒
61.
Tiacci E Schiavoni G Forconi F Santi A Trentin L Ambrosetti A Cecchini D Sozzi E Francia di Celle P Di Bello C Pulsoni A Foà R Inghirami G Falini B 《Blood》2012,119(1):192-195
Hairy cell leukemia (HCL) is a distinct clinicopathologic entity that responds well to purine analogs but is sometimes difficult to differentiate from HCL-like disorders (e.g., splenic marginal zone lymphoma and HCL variant). We recently identified the BRAF-V600E mutation as the disease-defining genetic event in HCL. In this study, we describe a new, simple, and inexpensive test for genetics-based diagnosis of HCL in whole-blood samples that detects BRAF-V600E through a sensitive allele-specific PCR qualitative assay followed by agarose-gel electrophoresis. This approach detected BRAF-V600E in all 123 leukemic HCL samples investigated containing as few as 0.1% leukemic cells. BRAF-V600E was detected at different time points during the disease course, even after therapy, pointing to its pivotal role in HCL pathogenesis and maintenance of the leukemic clone. Conversely, 115 non-HCL chronic B-cell neoplasms, including 79 HCL-like disorders, were invariably negative for BRAF-V600E. This molecular assay is a powerful tool for improving the diagnostic accuracy in HCL. 相似文献
62.
J Tang DJ Humes E Gemmil NT Welch SL Parsons JA Catton 《Annals of the Royal College of Surgeons of England》2013,95(5):323-328
Introduction
The high mortality and morbidity associated with resection for oesophagogastric malignancy has resulted in a conservative approach to the postoperative management of this patient group. In August 2009 we introduced an enhanced recovery after surgery (ERAS) pathway tailored to patients undergoing resection for oesophagogastric malignancy. We aimed to assess the impact of this change in practice on standard clinical outcomes.Methods
Two cohorts were studied of patients undergoing resection for oesophagogastric malignancy before (August 2008 – July 2009) and after (August 2009 – July 2010) the implementation of the ERAS pathway. Data were collected on demographics, interventions, length of stay, morbidity and in-hospital mortality.Results
There were 53 and 55 oesophagogastric resections undertaken respectively for malignant disease in each of the study periods. The median length of stay for both gastric and oesophageal resection decreased from 15 to 11 days (Mann– Whitney U, p<0.001) following implementation of the ERAS pathway. There was no significant increase in morbidity (gastric resection 23.1% vs 5.3% and oesophageal resection 25.9% vs 16.7%) or mortality (gastric resection no deaths and oesophageal resection 1.8% vs 3.6%) associated with the changes. There was a significant decrease in the number of oral contrast studies used following oesophageal resection, with a reduction from 21 (77.8%) in 2008–2009 to 6 (16.7%) in 2009–2010 (chi-squared test, p<0.0001).Conclusions
The introduction of an enhanced recovery programme following oesophagogastric surgery resulted in a significant decrease in length of median patient stay in hospital without a significant increase in associated morbidity and mortality. 相似文献63.
Javed F Utreja A Bello Correa FO Al-Askar M Hudieb M Qayyum F Al-Rasheed A Almas K Al-Hezaimi K 《Critical reviews in oncology/hematology》2012,83(3):303-309
Leukemia is a malignancy of the bone marrow. Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy and accounts for nearly 75% of all newly diagnosed leukemias and 25% of all malignancies in childhood. The aim of the present study was to review the oral health status in children with ALL. Databases were explored using various combinations of the following keywords: "acute lymphoblastic leukemia", "children", "inflammation", "pediatric", "periodontal disease" and "periodontitis". Oral inflammatory conditions including chelitis, gingivitis, herpetic gingivostomatitis, mucositis, oral candidiasis, periodontitis and ulcerations are common manifestations in children with ALL. RESULTS: Periodontal inflammatory conditions and oral mucositis were reported to be significantly higher in children with ALL as compared to healthy controls. Tooth morphological disorders including agenesis, microdontia, short roots and developmental defects in the enamel and dentin were more often observed in children with ALL as compared to healthy controls. Children with ALL have a reduced salivary flow rate, which makes them more susceptible to dental caries as compared to healthy children. Malocclusion due to microdontia may also trigger temporomandibular joint disorders in children with ALL; however, this relationship needs further investigations. CONCLUSION: Oral inflammatory conditions including mucositis and gingivitis are common in children with ALL as compared to healthy children. Tooth morphological disorders including microdontia and enamel and dentin are common manifestations in children with ALL. 相似文献
64.
65.
G. Canaud N. Kamar D. Anglicheau L. Esposito M. Rabant L.‐H. Noël C. Guilbeau‐Frugier R. Sberro‐Soussan A. Del Bello F. Martinez J. Zuber L. Rostaing C. Legendre 《American journal of transplantation》2013,13(8):2179-2185
Thrombotic microangiopathy (TMA) is one of the hallmark vascular lesions of antiphospholipid syndrome nephropathy (APSN). These lesions are at high risk of recurrence after kidney transplantation. The complement pathway is thought to be active in this process. We used eculizumab to treat three consecutive kidney transplant recipients with posttransplant TMA due to APSN recurrence that was resistant to plasmapheresis and explored the complement deposition and apoptotic and vascular cell markers on the sequential transplant biopsies. Treatment with eculizumab resulted in a rapid and dramatic improvement of the graft function in all three patients and in improvement of the TMA lesions within the graft. None of these patients had TMA flares after eculizumab was withdrawn. At the time of TMA diagnosis, immunofluorescence studies revealed intense C5b‐9 and C4d depositions at the endothelial cell surface of the injured vessels. Moreover, C5b‐9 colocalized with vessels exhibiting a high rate of apoptotic cells. Examination of sequential biopsies during eculizumab therapy showed that TMA lesions, C4d and apoptotic markers were rapidly cleared but the C5b‐9 deposits persisted for several months as a footprint of the TMA. Finally, we noticed that complement inhibition did not prevent the development of the chronic vascular changes associated with APSN. Eculizumab seems to be an efficient method for treating severe forms of posttransplant TMA due to APSN recurrence. Terminal complement inhibition does not prevent the development of chronic APSN. 相似文献
66.
V. P. Djientcheu T. F. Mouafo A. Esiene Y. N. Kamga S. Nguefack F. Bello T. Y. Yamgoue Z. C. Ongolo E. Mbonda 《Child's nervous system》2013,29(1):119-123
Introduction
Intracranial suppurations (ICS) are collections of pus of infectious origin in the skull. The authors present their experience.Patients and method
All children operated for ICS at the Central Hospital of Yaoundé from January 2000 to December 2008 were retrospectively included.Results
Thirty-five patients were recruited: 26 (74.29 %) males and 9 (25.71 %) females. These represent 82.9 % of all ICS operated in our institution. ICS represented 14.3 % of intracranial space-occupying lesions. The mean age was 8.34 years. They presented with headaches (80.77 %), altered consciousness (20 %), convulsions (76 %), vomiting (20 %), unilateral motor deficit (69.23 %), speech disorders (12 %), and fever (89.29 %). Bergman’s triad (51.86 %) was frequent. The primary infection was: meningitis, eight cases (22.85 %); sinusitis, six cases (17.14 %); head trauma, five cases (14.28 %); otitis media, one case (2.85 %); suppurations of the face, three cases (8.56 %); cardiopathy, one case (2.85 %); and craniotomy, one case (2.85 %). In seven cases (20 %), the origin was unknown. The lesions were empyema in 23 cases (65.71 %), cerebral abscess in 8 cases (22.85 %) and pyoventriculitis in 2 cases (5.72 %). The surgical procedures were burr holes (88.89 % of empyemas) and trepano-puncture–aspiration (75 % of abscesses). The mortality (21.42 %) and morbidity (42.85 %) were recorded.Conclusion
ICS are frequent but preventable (early treatment of the primary infection) pathologies of childhood in developing countries. Burr hole drainage (empyemas) and puncture–aspiration (abscesses) are simple, safe, and effective techniques. 相似文献67.
68.
69.